Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Asparaginase Erwinia Chrysanthemi (recombinant)
DRUG
2 trials
Sponsors
Jazz Pharmaceuticals
, Joanna Yi
Conditions
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Lymphoblastic Lymphoma
Pediatric AML
Early Phase 1
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
Recruiting
NCT07059975
Joanna Yi
Acute Myeloid Leukemia, Pediatric AML
Start: 2025-10-22
End: 2031-08-31
Target: 36
Updated: 2025-11-04
Unknown Phase
JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase
NCT04943952
Jazz Pharmaceuticals
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Updated: 2021-08-03
Related Papers
Update AML: Updated disease monitoring and treatment to enhance outcomes for pediatric AML (NCT07059975)
Blood
2025-11-03